The mechanisms of action of monoclonal antibodies and intravenous immunoglobulin include cytolysis of target cells through complement or antibody-dependent cell-mediated cytotoxicity, induction of ...

Researchers at the Ragon Institute have made a significant discovery about how antibodies can directly enhance the body's ...

HK) presented the mechanism of action (MOA) research findings of ... leading to superior antitumor efficacy compared to anti-CLDN18.2 monoclonal antibodies. In subcutaneous tumor xenograft models ...

Monoclonal antibodies against SARS-CoV-2 were considered a promising approach for the prevention and therapy of coronavirus ...

These antibodies are designed with two distinct binding sites, allowing them to simultaneously engage with two different antigens. This dual-targeting mechanism provides a level of precision that ...

GV20 Therapeutics (GV20), a clinical-stage AI-powered biotherapeutics company, today announced that Dr. Kristopher Wentzel ...

This country research report on Vietnam Cancer Monoclonal Antibody Market offers comprehensive insights into the market landscape, customer intelligence, and competitive strategies in the Vietnam ...

Phanes Therapeutics begins patient dosing in clinical study of mavrostobart in combination with chemotherapy: San Diego Wednesday, May 28, 2025, 18:00 Hrs [IST] Phanes Therapeutic ...

Merus N.V. (NASDAQ:MRUS), a clinical-stage oncology company with a market capitalization of $2.8 billion, has announced the publication detailing the mechanism ... these antibodies share several ...

Non-Hodgkin’s Lymphoma Pipeline Outlook Key Takeaways from the Non-Hodgkin Lymphoma Pipeline Report Mosunetuzumab is an investigational, humanized, T-cell bispecific antibody designed to engage ...

Merus N.V. (NASDAQ:MRUS), a clinical-stage oncology company with a market capitalization of $2.8 billion, has announced the publication detailing the mechanism of action for its investigational ...